Recommended Topic Related To:

Dextrose 5 in .9 Sodium Chloride

"Foodborne illness is a serious health risk for pregnant women and their unborn babies. Learn about easy food safety tips that can keep you and your unborn baby healthy this holiday season.

The holiday season is a very exciting time of y"...

Dextrose 5% in 0.9% Sodium Chloride

INDICATIONS

Dextrose and Sodium Chloride Injection, USP is indicated as a source of water, electrolytes, and calories.

DOSAGE AND ADMINISTRATION

As directed by a physician. Dosage is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile equipment.

As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low weight infants, because of the increased risk of hyperglycemia/hypoglycemia.

Additives may be incompatible. Complete information is not available.

Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the physician, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. Do not store solutions containing additives.

HOW SUPPLIED

Dextrose and Sodium Chloride Injection, USP (dextrose and sodium chloride inj) in VIAFLEX plastic container is supplied as follows:

Code Size (mL) NDC Product Name
2B1023 500 0338-0073-03 2.5% Dextrose and 0.45% Sodium Chloride Injection, USP
2B1024 1000 0338-0073-04
2B1092 250 0338-0077-02 5% Dextrose and 0.2% Sodium Chloride Injection, USP
2B1093 500 0338-0077-03
2B1094 1000 0338-0077-04
2B1082 250 0338-0081-02 5% Dextrose and 0.33% Sodium Chloride Injection, USP
2B1083 500 0338-0081-03
2B1084 1000 0338-0081-04
2B1072 250 0338-0085-02 5% Dextrose and 0.45% Sodium Chloride Injection, USP
2B1073 500 0338-0085-03
2B1074 1000 0338-0085-04
2B1062 250 0338-0089-02 5% Dextrose and 0.9% Sodium Chloride Injection, USP
2B1063 500 0338-0089-03
2B1064 1000 0338-0089-04
2B1163 500 0338-0095-03 10% Dextrose and 0.9% Sodium Chloride Injection, USP
2B1164 1000 0338-0095-04

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C); brief exposure up to 40°C does not adversely affect the product.

Directions for use of VIAFLEX plastic container

WARNING: Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed.

To Open

Tear overwrap down side at slit and remove solution container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.

Preparation for Administration

  1. Suspend container from eyelet support.
  2. Remove protector from outlet port at bottom of container.
  3. Attach administration set. Refer to complete directions accompanying set.

To Add Medication

WARNING: Additives may be incompatible.

To add medication before solution administration

  1. Prepare medication site.
  2. Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.
  3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during solution administration

  1. Close clamp on the set.
  2. Prepare medication site.
  3. Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.
  4. Remove container from IV pole and/or turn to an upright position.
  5. Evacuate both ports by squeezing them while container is in the upright position.
  6. Mix solution and medication thoroughly.
  7. Return container to in use position and continue administration.

Rev Aug 2003. Baxter Healthcare Corporation, Deerfield, IL 60015, USA. FDA Rev date: 6/2/2004

Last reviewed on RxList: 10/3/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Weight Loss Wisdom

Get tips, recipes and inspiration.